Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Amgen plans to lay off 350 former Horizon employees after $28B buyout
Fierce Pharma
Tue, 10/24/23 - 07:54 pm
Amgen
Horizon Therapeutics
layoffs
M&A
Roche pays $7.1B to Roivant for rights to Telavant’s IBD candidate
BioSpace
Mon, 10/23/23 - 10:35 am
Roche
M&A
Televant
Roivant
RVT-3101
IBD
ulcerative colitis
Crohn’s disease
Jazz looks at strategic options, including possible sale or unit divestiture
Fierce Pharma
Fri, 10/20/23 - 11:58 am
Jazz Pharma
Xyrem
M&A
Pfizer wins unconditional EU antitrust okay for $43 billion Seagen buy
Reuters
Thu, 10/19/23 - 10:45 pm
Pfizer
Seagen
M&A
Europe
Lilly links up European ADC network, snagging Elahere rival in latest biotech buy
Fierce Biotech
Thu, 10/19/23 - 10:10 am
Eli Lilly
M&A
antibody-drug conjugate
Elahere
Mablink
Takeda ponies up €130M to settle tax linked to distant AbbVie-Shire breakup fee
Fierce Pharma
Wed, 10/18/23 - 07:37 pm
Takeda
AbbVie
Shire
M&A
legal
Activist Icahn sues Illumina board over Grail acquisition
Reuters
Tue, 10/17/23 - 09:43 pm
Illumina
Grail
M&A
Carl Icahn
Thermo Fisher Scientific to buy Olink in $3.1 billion deal
Reuters
Tue, 10/17/23 - 11:50 am
Thermo Fisher Scientific
M&A
Olink
Medtech
drug discovery
EU to Order Illumina to Sell Grail After Years of Regulatory Challenges
BioSpace
Wed, 10/11/23 - 10:04 am
Illumina
Grail
diagnostics
M&A
Europe
5 financial challenges facing the medtech sector
Medtech Dive
Tue, 10/10/23 - 11:50 pm
Medtech
revenue
M&A
spinoffs
funding
IPOs
EU regulatory order for Illumina to sell Grail could come next week
Reuters
Mon, 10/9/23 - 10:18 am
Illumina
Grail
M&A
Europe
diagnostics
Medtech
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
CP Wire/Businesswire
Sun, 10/8/23 - 06:16 pm
Bristol Myers Squibb
M&A
Mirati Therapeutics
oncology
cancer
Krazati
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Tue, 10/10/23 - 05:29 pm
Bristol Myers Squibb
M&A
Mirati Therapeutics
oncology
Amgen Completes $27.8B Horizon Acquisition Following FTC Challenge
BioSpace
Fri, 10/6/23 - 11:37 am
Amgen
Horizon Therapeutics
FTC
M&A
Impel, trying to propel itself through financial woes, searches for potential buyer
Fierce Biotech
Fri, 10/6/23 - 10:11 am
Impel Pharma
M&A
bankruptcy
Months after FDA slam, AbbVie buys Parkinson’s disease drugmaker Mitokinin
Medical Marketing and Media
Thu, 10/5/23 - 09:15 pm
AbbVie
M&A
Mitokinin
Parkinson's Disease
Sanofi weighs Mirati buy as KRAS cancer drug battle enters new phase
Fierce Pharma
Thu, 10/5/23 - 09:10 pm
Mirati Therapeutics
Sanofi
M&A
KRAS inhibitors
Kyowa Kirin to acquire Orchard Therapeutics for $478 million
Reuters
Thu, 10/5/23 - 11:43 am
Kyowa Kirin
Orchard Therapeutics
M&A
Sharp acquires Berkshire Sterile Manufacturing
Biopharma Reporter
Thu, 10/5/23 - 11:30 am
SHARP
M&A
Berkshire Sterile Manufacturing
CDMO
drug manufacturing
Lilly Deepens Oncology Pipeline with $1.4B Point Biopharma Purchase
BioSpace
Tue, 10/3/23 - 11:59 am
Eli Lilly
oncology
M&A
Point Biopharma
radioligand
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »